-+ 0.00%
-+ 0.00%
-+ 0.00%

Hailey Biotech announced on December 12 that the company plans to acquire the remaining 41% of Shaanxi Ruisheng Biotechnology Co., Ltd. After the transaction is completed, the shareholding ratio of Ruisheng Biotech will reach 96%. This transaction constitutes a related transaction and does not constitute a major asset restructuring.

Zhitongcaijing·12/12/2025 10:49:04
Listen to the news
Hailey Biotech announced on December 12 that the company plans to acquire the remaining 41% of Shaanxi Ruisheng Biotechnology Co., Ltd. After the transaction is completed, the shareholding ratio of Ruisheng Biotech will reach 96%. This transaction constitutes a related transaction and does not constitute a major asset restructuring.